154 related articles for article (PubMed ID: 15785794)
1. Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases.
Anthonisen NR; Woodlrage K; Manfreda J
Can Respir J; 2005 Mar; 12(2):69-74. PubMed ID: 15785794
[TBL] [Abstract][Full Text] [Related]
2. Spirometry and obstructive lung disease in Manitoba.
Anthonisen NR; Dik N; Manfreda J; Roos LL
Can Respir J; 2001; 8(6):421-6. PubMed ID: 11753455
[TBL] [Abstract][Full Text] [Related]
3. Which patients are prescribed inhaled anti-asthma drugs?
Roberts SJ; Bateman DN
Thorax; 1994 Nov; 49(11):1090-5. PubMed ID: 7831622
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care].
Miravitlles M; Murio C; Guerrero T; Segú JL
Arch Bronconeumol; 1999 Apr; 35(4):173-8. PubMed ID: 10330538
[TBL] [Abstract][Full Text] [Related]
5. Changed terms for drug payment influenced GPs' diagnoses and prescribing practice for inhaled corticosteroids.
Dalbak LG; Rognstad S; Melbye H; Straand J
Eur J Gen Pract; 2013 Jun; 19(2):106-10. PubMed ID: 23560809
[TBL] [Abstract][Full Text] [Related]
6. Physician perceptions and management of COPD.
Kesten S; Chapman KR
Chest; 1993 Jul; 104(1):254-8. PubMed ID: 8325079
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey.
Jackevicius CA; Chapman KR
Ann Pharmacother; 1997 Feb; 31(2):160-4. PubMed ID: 9034414
[TBL] [Abstract][Full Text] [Related]
8. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
[TBL] [Abstract][Full Text] [Related]
9. Prescribing of beta-2 agonists and inhaled steroids in England: trends between 1992 and 1998, and association with material deprivation, chronic illness and asthma mortality rates.
Majeed A; Ferguson J; Field J
J Public Health Med; 1999 Dec; 21(4):395-400. PubMed ID: 11469360
[TBL] [Abstract][Full Text] [Related]
10. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic status, drug insurance benefits, and new prescriptions for inhaled corticosteroids in schoolchildren with asthma.
Kozyrskyj AL; Mustard CA; Simons FE
Arch Pediatr Adolesc Med; 2001 Nov; 155(11):1219-24. PubMed ID: 11695930
[TBL] [Abstract][Full Text] [Related]
12. Medication prescribing for asthma and COPD: a register-based cross-sectional study in Swedish primary care.
Weidinger P; Nilsson JL; Lindblad U
BMC Fam Pract; 2014 Mar; 15():54. PubMed ID: 24666507
[TBL] [Abstract][Full Text] [Related]
13. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice.
Griffiths C; Feder G; Wedzicha J; Foster G; Livingstone A; Marlowe GS
Respir Med; 1999 Dec; 93(12):903-8. PubMed ID: 10653053
[TBL] [Abstract][Full Text] [Related]
15. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease.
Cramer JA; Bradley-Kennedy C; Scalera A
Can Respir J; 2007; 14(1):25-9. PubMed ID: 17315055
[TBL] [Abstract][Full Text] [Related]
16. Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995.
Van Andel AE; Reisner C; Menjoge SS; Witek TJ
Chest; 1999 Mar; 115(3):703-7. PubMed ID: 10084479
[TBL] [Abstract][Full Text] [Related]
17. Prehospitalization inhaled corticosteroid use in patients with COPD or asthma.
Jackevicius C; Joyce DP; Kesten S; Chapman KR
Chest; 1997 Feb; 111(2):296-302. PubMed ID: 9041972
[TBL] [Abstract][Full Text] [Related]
18. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive lung disease (COPD)].
van Schayck CP; Postma DS; Lammers JW
Ned Tijdschr Geneeskd; 1999 Jan; 143(3):137-40. PubMed ID: 10086126
[TBL] [Abstract][Full Text] [Related]
19. Are ICD-10 codes appropriate for performance assessment in asthma and COPD in general practice? Results of a cross sectional observational study.
Schneider A; Gantner L; Maag I; Borst MM; Wensing M; Szecsenyi J
BMC Health Serv Res; 2005 Feb; 5(1):11. PubMed ID: 15683548
[TBL] [Abstract][Full Text] [Related]
20. An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.
McGowan B; Bennett K; Barry M; Owens M; O'Connor M
Ir Med J; 2009 Mar; 102(3):73-6. PubMed ID: 19489193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
